Home

John C Thomas

CIK 1424620 · CFO and Secretary · last filed 2026-06-17

John C Thomas is a CFO and Secretary who has filed 43 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for DWTX, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $664.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$664.9K

Companies

7

Total Filings

43

Lifetime Open-Market Net

-$1.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DWTX Director — $1.55 — $0 3 2026-06-17
Dogwood Therapeutics, Inc. (VIRI) Delisted Director 40 $3.88 $155 $5.7K 5 2024-02-28
ImmunityBio, Inc. (NK) Delisted Director 221,363 — — -$1.92M 19 2020-12-11
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director — — — $0 2 2018-08-13
Innoveren Scientific, Inc. (MDVXW) Delisted Director 109,960 — — $0 2 2017-11-01
QLTI Director 24,500 $27.14 $664.9K $0 7 2016-06-21
Midatech Pharma US Inc. (DARA) Delisted CFO and Secretary 5,945 — — $0 3 2012-05-17

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-17 DWTX Grant (A) — $0 EDGAR
2025-07-01 DWTX Grant (A) — $0 EDGAR
2025-06-23 DWTX Grant (A) — $0 EDGAR
2024-02-28 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2023-06-20 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2022-06-30 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2022-01-04 Dogwood Therapeutics, Inc. (VIRI) Delisted Buy (P) +1,000 $5.7K EDGAR
2021-06-23 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2020-12-11 ImmunityBio, Inc. (NK) Delisted Sell (S) −42,592 -$461.1K EDGAR
2020-08-21 ImmunityBio, Inc. (NK) Delisted Sell (S) −20,000 -$183.8K EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.